Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Stanulla

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
Nature Medicine|February 3, 2009
NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathwayJulia Skokowa, Dan Lan, Basant Kumar Thakur, et al.
Blood|April 10, 2010
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocolGunnar Cario, Martin Zimmermann, Renja Romey, et al.
Genes, Chromosomes & Cancer|June 28, 2020
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocolMareike Jung, Maximilian Schieck, Winfried Hofmann, et al.
Blood|November 28, 2014
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS)Sarah Krause, Christian Pfeiffer, Susanne Strube, et al.
Pediatric Blood & Cancer|April 4, 2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhoodJuliane Schmäh, Birthe Fedders, Renate Panzer-Grümayer, et al.
Blood|June 19, 2009
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocolsMartin Stanulla, Elke Schaeffeler, Anja Möricke, et al.
Blood|June 15, 2011
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartmentMaike Schmitz, Petra Breithaupt, Nastassja Scheidegger, et al.
BMC Cancer|June 20, 2018
MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κBDavid M Cordas Dos Santos, Juliane Eilers, Alfonso Sosa Vizcaino, et al.
Cancers|September 10, 2021
The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic LeukemiaJonathan Lukas Lühmann, Marie Stelter, Marie Wolter, et al.
Haematologica|August 6, 2013
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolGunnar Cario, Peter Rhein, Rita Mitlöhner, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Nature Medicine|February 3, 2009
NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathwayJulia Skokowa, Dan Lan, Basant Kumar Thakur, et al.
Blood|April 10, 2010
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocolGunnar Cario, Martin Zimmermann, Renja Romey, et al.
Genes, Chromosomes & Cancer|June 28, 2020
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocolMareike Jung, Maximilian Schieck, Winfried Hofmann, et al.
Blood|November 28, 2014
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS)Sarah Krause, Christian Pfeiffer, Susanne Strube, et al.
Pediatric Blood & Cancer|April 4, 2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhoodJuliane Schmäh, Birthe Fedders, Renate Panzer-Grümayer, et al.
Blood|June 19, 2009
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocolsMartin Stanulla, Elke Schaeffeler, Anja Möricke, et al.
Blood|June 15, 2011
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartmentMaike Schmitz, Petra Breithaupt, Nastassja Scheidegger, et al.
BMC Cancer|June 20, 2018
MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κBDavid M Cordas Dos Santos, Juliane Eilers, Alfonso Sosa Vizcaino, et al.
Cancers|September 10, 2021
The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic LeukemiaJonathan Lukas Lühmann, Marie Stelter, Marie Wolter, et al.
Haematologica|August 6, 2013
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolGunnar Cario, Peter Rhein, Rita Mitlöhner, et al.
Pageof 15